重症患者谵妄管理专家共识
本共识由中国冷静治疗研究组组织15位专家起草、36位专家以德尔菲法复评,按GRADE原则对每条陈述分级。共识共31条,涵盖谵妄的本质与诊断、危险因素(疼痛、焦虑抑郁、睡眠障碍、撤药反应等)、亚临床谵妄的联合筛查、病因治疗为核心的管理、环境与睡眠管理、早期活动、家属参与、右美托咪定及抗精神病药使用注意事项,以及ABCDEF、eCASH、ESCAPE等多策略管理。共识旨在规范重症患者谵妄管理、优化镇痛镇静治疗并改善预后。
要点
- 急性意识改变和注意力缺陷是谵妄诊断的必要条件,需每日评估以早期发现谵妄。
- 联合使用ICU意识模糊评估法(CAM-ICU)与重症监护谵妄筛查量表(ICDSC)可提高谵妄尤其是亚临床谵妄的敏感性。
- 早期识别并干预亚临床谵妄可降低其进展为临床谵妄的风险。
- 谵妄管理的关键是病因治疗,同时改善环境因素、加强沟通、早期活动与睡眠管理有助于减少谵妄发生。
- 右美托咪定可缩短高活动型谵妄的持续时间或预防谵妄;使用抗精神病药治疗谵妄时应警惕其对心律的影响。
适用人群与场景
- 重症患者,适用于ICU场景的谵妄管理。
诊断标准与关键阈值
- 谵妄诊断的必要条件为急性意识改变和注意力缺陷。
- 联合使用ICU意识模糊评估法(CAM-ICU)与重症监护谵妄筛查量表(ICDSC)可提高谵妄尤其是亚临床谵妄的筛查敏感性。
- 应对谵妄严重程度进行评估,严重程度评估是谵妄诊断的必要组成部分。
- 需注意谵妄与痴呆/抑郁的鉴别诊断。
- 高活动型和混合型谵妄常见,应予以重视。
处置流程与药物剂量
- 谵妄管理的关键是病因治疗。
- 改善环境因素、使患者舒适有助于减少谵妄。
- 早期运动可降低谵妄发生率并缩短谵妄持续时间。
- 应重视并加强与患者的沟通,家属参与有助于降低谵妄发生率并促进谵妄恢复。
- 重视睡眠管理在谵妄预防和治疗中的作用。
- 右美托咪定可缩短高活动型谵妄的持续时间或预防谵妄。
- 使用抗精神病药治疗谵妄时,应警惕其对心律的影响。
- 谵妄管理应重视脑功能锻炼,并可采取ABCDEF、eCASH、ESCAPE等多策略管理以预防和治疗谵妄、改善预后。
红旗征与不能漏的情况
- 应警惕持续或反复谵妄的潜在危险因素。
- 疼痛是重症患者谵妄的常见原因,镇痛可减少谵妄的发生和发展。
- 焦虑或抑郁是重症患者谵妄的重要因素。
- 应注意谵妄与撤药反应的关系,并注意谵妄与药物依赖/撤药反应的关系。
- 睡眠中断可诱发谵妄。
- 重症疾病相关谵妄可影响原发病的诊治,也可随原发病好转而缓解;与非重症疾病相关谵妄相比,重症疾病相关谵妄的缓解不会一蹴而就。
研究设计与关键结果
- 由中国冷静治疗研究组组织15位专家成立专门委员会,按GRADE原则对每条陈述进行评估,再由36位专家采用德尔菲法对所有陈述进行复评,最终形成31条专家共识。
证据类型、等级与局限
- 证据类型:专家共识;采用GRADE原则评估证据,并以德尔菲法由36位专家复评。
- 局限:原文未报告局限性。
对床旁实践的改变
- 在ICU应每日评估谵妄,联合CAM-ICU与ICDSC以提高对谵妄尤其是亚临床谵妄的识别敏感性,并早期干预亚临床谵妄以降低其进展为临床谵妄的风险。
- 谵妄管理以病因治疗为关键,同时改善环境、加强沟通、鼓励家属参与、早期运动及睡眠管理,并可采用ABCDEF、eCASH、ESCAPE等多策略。
- 使用右美托咪定可缩短高活动型谵妄持续时间或预防谵妄;使用抗精神病药治疗谵妄时应警惕对心律的影响。
- 缩短谵妄持续时间可减少长期认知功能障碍的发生;多学科合作与持续质量改进可改善谵妄管理。
指南或共识出处
- 指南名称:重症患者谵妄管理专家共识(Experts consensus on the management of delirium in critically ill patients);发布机构:中国冷静治疗研究组(Chinese Critical Hypothermia-Sedation Therapy Study Group)。
提炼说明
- 本条依据论文摘要整理;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
To establish the experts consensus on the management of delirium in critically ill patients. A special committee was set up by 15 experts from the Chinese Critical Hypothermia-Sedation Therapy Study Group. Each statement was assessed based on the GRADE (Grading of Recommendations Assessment, Development, and Evaluation) principle. Then the Delphi method was adopted by 36 experts to reassess all the statements. (1) Delirium is not only a mental change, but also a clinical syndrome with multiple pathophysiological changes. (2) Delirium is a form of disturbance of consciousness and a manifestation of abnormal brain function. (3) Pain is a common cause of delirium in critically ill patients. Analgesia can reduce the occurrence and development of delirium. (4) Anxiety or depression are important factors for delirium in critically ill patients. (5) The correlation between sedative and analgesic drugs and delirium is uncertain. (6) Pay attention to the relationship between delirium and withdrawal reactions. (7) Pay attention to the relationship between delirium and drug dependence/withdrawal reactions. (8) Sleep disruption can induce delirium. (9) We should be vigilant against potential risk factors for persistent or recurrent delirium. (10) Critically illness related delirium can affect the diagnosis and treatment of primary diseases, and can also be alleviated with the improvement of primary diseases. (11) Acute change of consciousness and attention deficit are necessary for delirium diagnosis. (12) The combined assessment of confusion assessment method for the intensive care unit and intensive care delirium screening checklist can improve the sensitivity of delirium, especially subclinical delirium. (13) Early identification and intervention of subclinical delirium can reduce its risk of clinical delirium. (14) Daily assessment is helpful for early detection of delirium. (15) Hopoactive delirium and mixed delirium are common and should be emphasized. (16) Delirium may be accompanied by changes in electroencephalogram. Bedside electroencephalogram monitoring should be used in the ICU if conditions warrant. (17) Pay attention to differential diagnosis of delirium and dementia/depression. (18) Pay attention to the role of rapid delirium screening method in delirium management. (19) Assessment of the severity of delirium is an essential part of the diagnosis of delirium. (20) The key to the management of delirium is etiological treatment. (21) Improving environmental factors and making patient comfort can help reduce delirium. (22) Early exercise can reduce the incidence of delirium and shorten the duration of delirium. (23) Communication with patients should be emphasized and strengthened. Family members participation can help reduce the incidence of delirium and promote the recovery of delirium. (24) Pay attention to the role of sleep management in the prevention and treatment of delirium. (25) Dexmedetomidine can shorten the duration of hyperactive delirium or prevent delirium. (26) When using antipsychotics to treat delirium, we should be alert to its effect on the heart rhythm. (27) Delirium management should pay attention to brain functional exercise. (28) Compared with non-critically illness related delirium, the relief of critically illness related delirium will not accomplished at one stroke. (29) Multiple management strategies such as ABCDEF, eCASH and ESCAPE are helpful to prevent and treat delirium and improve the prognosis of critically ill patients. (30) Shortening the duration of delirium can reduce the occurrence of long-term cognitive impairment. (31) Multidisciplinary cooperation and continuous quality improvement can improve delirium management. Consensus can promote delirium management in critically ill patients, optimize analgesia and sedation therapy, and even affect prognosis.
谵妄是ICU中常见的一种急性临床综合征,可导致患者病死率增加,机械通气时间和住院时间延长,引起长期的认知功能障碍,增加医疗费用,严重影响患者的预后。为规范重症患者的谵妄管理,由中国冷静治疗研究组根据国内外最新文献资料和多年来的应用推广经验,组织相关重症医学专家在充分讨论和沟通基础上制定了"重症患者谵妄管理专家共识"。旨在改进重症患者的谵妄管理,优化镇痛镇静治疗,改善患者的预后。.
参考来源
- Tang B, Wang XT, Chen WJ, et al. [Experts consensus on the management of delirium in critically ill patients]. Zhonghua Nei Ke Za Zhi. 2019. PMID: 30704197. doi:10.3760/cma.j.issn.0578-1426.2019.02.007
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。